Reply to B.L. King-Kallimanis et al.
Publication
, Journal Article
Friedman, DR; Halwani, AS; Kelley, MJ
Published in: JCO Clin Cancer Inform
July 2022
Duke Scholars
Published In
JCO Clin Cancer Inform
DOI
EISSN
2473-4276
Publication Date
July 2022
Volume
6
Start / End Page
e2200075
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Friedman, D. R., Halwani, A. S., & Kelley, M. J. (2022). Reply to B.L. King-Kallimanis et al. JCO Clin Cancer Inform, 6, e2200075. https://doi.org/10.1200/CCI.22.00075
Friedman, Daphne R., Ahmad S. Halwani, and Michael J. Kelley. “Reply to B.L. King-Kallimanis et al.” JCO Clin Cancer Inform 6 (July 2022): e2200075. https://doi.org/10.1200/CCI.22.00075.
Friedman DR, Halwani AS, Kelley MJ. Reply to B.L. King-Kallimanis et al. JCO Clin Cancer Inform. 2022 Jul;6:e2200075.
Friedman, Daphne R., et al. “Reply to B.L. King-Kallimanis et al.” JCO Clin Cancer Inform, vol. 6, July 2022, p. e2200075. Pubmed, doi:10.1200/CCI.22.00075.
Friedman DR, Halwani AS, Kelley MJ. Reply to B.L. King-Kallimanis et al. JCO Clin Cancer Inform. 2022 Jul;6:e2200075.
Published In
JCO Clin Cancer Inform
DOI
EISSN
2473-4276
Publication Date
July 2022
Volume
6
Start / End Page
e2200075
Location
United States